The Patent Finder

Maintenance fees coming due

Precision Biosciences, Inc.

7 maintenance fees come due in the 12 months from Nov 15, 2026, the next on Dec 20, 2026. Unpaid by Jun 21, 2027, that one lapses early.
A maintenance fee does not end a patent on its due date. It falls due at 3.5, 7.5 and 11.5 years from grant, and the patent lapses only if the fee is still unpaid at the end of the six month grace period that follows.
PatentTitleHolderStatusFee dueLapses if unpaidExpiresConfidence
US 11,680,254Engineered Meganucleases Specific for Recognition Sequences in the PCSK9 Gene
In force
Fee due Dec 20, 2026
Lapses if unpaid Jun 21, 2027
 · High confidence
Precision Biosciences, Inc.In forceDec 20, 2026Jun 21, 2027High confidence
US 11,753,630Polynucleotides Encoding Engineered Meganucleases Having Specificity for Recognition Sequences in the Dystrophin Gene
In force
Fee due Mar 12, 2027
Lapses if unpaid Sep 13, 2027
 · Medium confidence
Precision Biosciences, Inc.In forceMar 12, 2027Sep 13, 2027Medium confidence
US 11,786,554Optimized Engineered Nucleases Having Specificity for the Human T Cell Receptor Alpha Constant Region Gene
In force
Fee due Apr 17, 2027
Lapses if unpaid Oct 18, 2027
 · High confidence
Precision Biosciences, Inc.In forceApr 17, 2027Oct 18, 2027High confidence
US 11,788,077Polynucleotides Encoding Optimized Engineered Meganucleases Having Specificity for a Recognition Sequence in the Hepatitis B Virus Genome
In force
Fee due Apr 17, 2027
Lapses if unpaid Oct 18, 2027
 · High confidence
Precision Biosciences, Inc.In forceApr 17, 2027Oct 18, 2027High confidence
US 11,851,680Genetically-Modified Immune Cells Comprising a Microrna-Adapted Shrna (SHRNAMIR)
In force
Fee due Jun 26, 2027
Lapses if unpaid Dec 27, 2027
 · High confidence
Precision Biosciences, Inc.In forceJun 26, 2027Dec 27, 2027High confidence
US 11,866,747Engineered Meganucleases That Target Human Mitochondrial Genomes
In force
Fee due Jul 9, 2027
Lapses if unpaid Jan 10, 2028
 · Medium confidence
Precision Biosciences, Inc.In forceJul 9, 2027Jan 10, 2028Medium confidence
US 10,603,363Treatment of Retinitis Pigmentosa Using Engineered Meganucleases
In force
Fee due Sep 30, 2027
Lapses if unpaid Mar 31, 2028
 · High confidence
Precision Biosciences, Inc.In forceSep 30, 2027Mar 31, 2028High confidence
7 of 7 patents shown. Soonest fee due date first, then patent number.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited